{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:26:13Z","timestamp":1760189173300},"reference-count":12,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1525,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis & Rheumatism"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1002\/art.30266","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T16:39:07Z","timestamp":1296232747000},"page":"1779-1781","source":"Crossref","is-referenced-by-count":8,"title":["Methotrexate in juvenile localized scleroderma: Adding to the evidence"],"prefix":"10.1002","volume":"63","author":[{"given":"Ivan","family":"Foeldvari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,29]]},"reference":[{"key":"10.1002\/art.30266-BIB1|cit1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","article-title":"Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland","volume":"62","author":"Herrick","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1002\/art.30266-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30266-BIB3|cit3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1002\/art.30266-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: a work in progress toward development of localized scleroderma outcome measures","volume":"36","author":"Arkachaisri","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30266-BIB5|cit5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of Disease Damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30266-BIB6|cit6","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30266-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.1780371209","article-title":"Measurement of health status in children with juvenile rheumatoid arthritis","volume":"37","author":"Singh","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30266-BIB8|cit8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3899\/jrheum.090708","article-title":"Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists","volume":"37","author":"Li","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30266-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","article-title":"An evaluation of long-term outcomes in adults with pediatric-onset morphea","volume":"146","author":"Saxton-Daniels","year":"2010","journal-title":"Arch Dermatol"},{"issue":"Suppl","key":"10.1002\/art.30266-BIB10|cit10","first-page":"S701","article-title":"Localized scleroderma therapy: when would be a good time to stop?","volume":"62","author":"Arkachaisri","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30266-BIB11|cit11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11926-009-0028-y","article-title":"The use of Doppler ultrasound to evaluate lesions of localized scleroderma","volume":"11","author":"Li","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1002\/art.30266-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1002\/art.22920","article-title":"Laser Doppler flowmetry for assessing localized scleroderma in children","volume":"56","author":"Weibel","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis & Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.30266","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/art.30266\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T22:07:32Z","timestamp":1625090852000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.30266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,29]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1002\/art.30266","relation":{},"ISSN":["0004-3591"],"issn-type":[{"value":"0004-3591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,29]]}}}